Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae-authors' response

Chandra Datta Sumi¹, Jason A Roberts^{1

2

3

4}, Fekade B Sime¹

Affiliations

¹ The University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
² Department of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
³ Herston Infectious Diseases Institute (HeIDI), Metro North Health, Brisbane, Australia.
⁴ Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France.

Editorial

Chandra Datta Sumi et al. J Antimicrob Chemother. 2023.

. 2023 Mar 2;78(3):854-857.

doi: 10.1093/jac/dkad017.

Chandra Datta Sumi¹, Jason A Roberts^{1

2

3

4}, Fekade B Sime¹

¹ The University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
² Department of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
³ Herston Infectious Diseases Institute (HeIDI), Metro North Health, Brisbane, Australia.
⁴ Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France.

No abstract available

Comment on

Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae.
Sumi CD, Heffernan AJ, Naicker S, Islam K, Cottrell K, Wallis SC, Lipman J, Harris PNA, Sime FB, Roberts JA. Sumi CD, et al. J Antimicrob Chemother. 2020 Sep 1;75(9):2633-2640. doi: 10.1093/jac/dkaa211. J Antimicrob Chemother. 2020. PMID: 32585693
Comment on: Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae.
Giry M, Sarfati S, Pestel-Caron M, Wils J, Lamoureux F, Alexandre K. Giry M, et al. J Antimicrob Chemother. 2022 Sep 30;77(10):2892-2894. doi: 10.1093/jac/dkac150. J Antimicrob Chemother. 2022. PMID: 35538913 No abstract available.